KATHERINE NEWMAN: Open Payments
NPI 1558803841 · PLANT CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,947 in 106 payments from 20 companies in 2025. Trend: 2023 $2,283 · 2024 $2,454 · 2025 $1,947
Food & beverage: $1,947
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $364 |
| AstraZeneca Pharmaceuticals LP | 18 | $345 |
| Amgen Inc. | 19 | $262 |
| ABBVIE INC. | 15 | $203 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $124 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $83 |
| PFIZER INC. | 4 | $82 |
| GlaxoSmithKline, LLC. | 4 | $74 |
| Lilly USA, LLC | 3 | $71 |
| Novartis Pharmaceuticals Corporation | 3 | $68 |
Products named: Ozempic, AIRSUPRA, VRAYLAR, OTEZLA, JARDIANCE, FARXIGA, Kerendia, LEQVIO.
Industry payments across FL — which companies pay providers there.
